I'm most interested in the results of the second B-UP cohort as that appears to be the only likely upside driver in Q1. It's possible we see B-OM interim results in Q1 but I'm betting on Q2. If the second cohort of B-UP is great and the price responds we could be on our way. If not I think it gives safety to the shorts for a couple more months. Still, I'd much rather be long than short at this juncture regardless of the results.
I still believe we will see the Prurisol partnership in Q4 2017 - Q1 2018.
I'm very skeptical that we will see a Brilacidin partnership in 2017 but would love to see it happen.
(0)
(2)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
All content of my posts is my opinion and speculation. Do not treat anything I say as fact or actionable investment advice. I participate to challenge my investment thesis from any angle possible. Please do your own due diligence.